S
Sheila Govind
Researcher at Cranfield University
Publications - 23
Citations - 831
Sheila Govind is an academic researcher from Cranfield University. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 11, co-authored 21 publications receiving 710 citations. Previous affiliations of Sheila Govind include National Institute for Biological Standards and Control.
Papers
More filters
Journal ArticleDOI
Recommendations for enterovirus diagnostics and characterisation within and beyond Europe
Heli Harvala,Eeva Broberg,Kimberley S. M. Benschop,Natasa Berginc,Shamez N Ladhani,Petri Susi,Claus Christiansen,James McKenna,David J. Allen,Phoebe Makiello,Georgina McAllister,Mirabelli Carmen,Katherina Zakikhany,Robert Dyrdak,Xiaohui Chen Nielsen,Tina Vasehus Madsen,Joel Paul,Catherine Moore,Karin von Eije,Antonio Piralla,Mieke Carlier,Laura Vanoverschelde,Randy Poelman,Andrés Antón,F. Xavier López-Labrador,Laura Pellegrinelli,Kathrin Keeren,Melanie Maier,Hayley Cassidy,Stavros Derdas,Carita Savolainen-Kopra,Sabine Diedrich,Svein Arne Nordbø,Javier Buesa,Jean-Luc Bailly,Fausto Baldanti,Andrew Macadam,Audrey Mirand,Susanne Gjeruldsen Dudman,Isabelle Schuffenecker,Seilesh Kadambari,Johan Neyts,Michael J. Griffiths,Jan Richter,Cristina Margaretto,Sheila Govind,Ursula Morley,Ortwin Adams,Sidsel Krokstad,Jonathan Dean,Margarita Pons-Salort,Birgit Prochazka,María Cabrerizo,Manasi Majumdar,Gaia Nebbia,Maryse A. Wiewel,Simon Cottrell,Peter V. Coyle,Javier Martin,Catrin E. Moore,Sofie Midgley,Peter Horby,Katja C. Wolthers,Peter Simmonds,Hubert G. M. Niesters,Thea Kølsen Fischer +65 more
TL;DR: It is recommended that respiratory and stool samples in addition to cerebrospinal fluid and blood samples are submitted for EV testing from patients with suspected neurological infections and reverse transcriptase PCR targeting the 5'noncoding regions (5'NCR) should be used for diagnosis of EVs.
Journal ArticleDOI
CMV and Immunosenescence: from basics to clinics
Rafael Solana,Raquel Tarazona,Allison E. Aiello,Arne N. Akbar,Victor Appay,Mark Beswick,Jos A. Bosch,Jos A. Bosch,Carmen Campos,Sara Cantisán,Luka Cicin-Sain,Evelyna Derhovanessian,Sara Ferrando-Martinez,Daniela Frasca,Tamas Fulop,Sheila Govind,Beatrix Grubeck-Loebenstein,Ann B. Hill,Mikko Hurme,Florian Kern,Anis Larbi,Miguel López-Botet,Andrea B. Maier,Janet E. McElhaney,Paul Moss,Elissaveta Naumova,Janko Nikolich-Zugich,Alejandra Pera,Jerrald L. Rector,Natalie E. Riddell,Beatriz Sanchez-Correa,Paolo Sansoni,Delphine Sauce,René A. W. van Lier,George C. Wang,Mark R. Wills,Maciej Zieliński,Graham Pawelec +37 more
TL;DR: Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization ofCMV-specific T cells, impact of CMVs infection and ageing on innate immunity, and finally, most important, the clinical implications of immun Rosenescence and CMV infection.
Journal ArticleDOI
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
Pierre Olivier Lang,Aline Mendes,Jennifer Socquet,Noémie Assir,Sheila Govind,Richard Aspinall +5 more
TL;DR: How effective current influenza vaccine strategies are in the aging and older adult population is examined and which are the most important biases that interfere with measurements of influenza vaccine effectiveness are analyzed.
Journal ArticleDOI
Immunosenescence: Implications for vaccination programmes in adults
TL;DR: This review will first examine the evidence linking the contribution of immunosenescence to a less than optimal vaccine response in aged individuals in order to demonstrate that strategy of promoting vaccination in these populations is not sufficient to reduce the burden associated with VPDs.
Journal ArticleDOI
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience.
TL;DR: How effective current influenza-vaccine strategies are in aged adults is examined, by analysing which are the most important factors modulating the interpretation of study results in this population, and possible strategies to improve the ability of the senescent immune system to respond to vaccination are concluded.